This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Advancing the Treatment of People With Mental Illness: A Call to Action in the Management of Metabolic Issues

Article Abstract

Click to enlarge page

This ACADEMIC HIGHLIGHTS section of The Journal of Clinical Psychiatry presents a summary of the meeting "Advancing the Treatment of People With Mental Illness: A Call to Action in the Management of Metabolic Issues," held in Vienna, Austria, on September 29-30, 2004, convened by the World Federation for Mental Health, and supported by an unrestricted educational grant from Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. The meeting was cochaired by L. Patt Franciosi, Ph.D., President, Board of Directors, World Federation for Mental Health, Alexandria, Va., USA, and Professor Siegfried Kasper, Professor of Psychiatry and Chairman of the Department of General Psychiatry, Medical University of Vienna, Austria. Faculty information and disclosure appear at the end of this article. The World Federation for Mental Health has received project support during 2004 from AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer Ltd., Otsuka America Pharmaceutical, and Otsuka Pharmaceutical Ltd. All members of the faculty (including the cochairs) but not the observers contributed to the development of this report, and the final report was reviewed and approved by all faculty members prior to submission to the Journal.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 66

Quick Links: Metabolic Disorder , Side Effects-Medication